Literature DB >> 32534153

Significance of host heparanase in promoting tumor growth and metastasis.

Gan-Lin Zhang1, Lilach Gutter-Kapon2, Neta Ilan2, Tahira Batool3, Kailash Singh4, Andreas Digre3, Zhengkang Luo4, Stellan Sandler4, Yuval Shaked2, Ralph D Sanderson5, Xiao-Min Wang6, Jin-Ping Li7, Israel Vlodavsky8.   

Abstract

Heparanase, the sole heparan sulfate degrading endoglycosidase, regulates multiple biological activities that enhance tumor growth, angiogenesis and metastasis. Much of the impact of heparanase on tumor progression is related to its function in mediating tumor-host crosstalk, priming the tumor microenvironment to better support tumor growth and metastasis. We have utilized mice over-expressing (Hpa-tg) heparanase to reveal the role of host heparanase in tumor initiation, growth and metastasis. While in wild type mice tumor development in response to DMBA carcinogenesis was restricted to the mammary gland, Hpa-tg mice developed tumors also in their lungs and liver, associating with reduced survival of the tumor-bearing mice. Consistently, xenograft tumors (lymphoma, melanoma, lung carcinoma, pancreatic carcinoma) transplanted in Hpa-tg mice exhibited accelerated tumor growth and shorter survival of the tumor-bearing mice compared with wild type mice. Hpa-tg mice were also more prone to the development of metastases following intravenous or subcutaneous injection of tumor cells. In some models, the growth advantage was associated with infiltration of heparanase-high host cells into the tumors. However, in other models, heparanase-high host cells were not detected in the primary tumor, implying that the growth advantage in Hpa-tg mice is due to systemic factors. Indeed, we found that plasma from Hpa-tg mice enhanced tumor cell migration and invasion attributed to increased levels of pro-tumorigenic factors (i.e., RANKL, SPARC, MIP-2) in the plasma of Hpa-Tg vs. wild type mice. Furthermore, tumor aggressiveness and short survival time were demonstrated in wild type mice transplanted with bone marrow derived from Hpa-tg but not wild type mice. These results were attributed, among other factors, to upregulation of pro-tumorigenic (i.e., IL35+) and downregulation of anti-tumorigenic (i.e., IFN-γ+) T-cell subpopulations in the spleen, lymph nodes and blood of Hpa-tg vs. wild type mice and their increased infiltration into the primary tumor. Collectively, our results emphasize the significance of host heparanase in mediating the pro-tumorigenic and pro-metastatic interactions between the tumor cells and the host tumor microenvironment, immune cells and systemic factors.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heparanase; Host factors; Immune cells; Metastasis; Tumor microenvironment

Year:  2020        PMID: 32534153      PMCID: PMC7704762          DOI: 10.1016/j.matbio.2020.06.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  83 in total

1.  Heparanase-mediated loss of nuclear syndecan-1 enhances histone acetyltransferase (HAT) activity to promote expression of genes that drive an aggressive tumor phenotype.

Authors:  Anurag Purushothaman; Douglas R Hurst; Claudio Pisano; Shuji Mizumoto; Kazuyuki Sugahara; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

2.  MicroRNA-26a/-26b-COX-2-MIP-2 Loop Regulates Allergic Inflammation and Allergic Inflammation-promoted Enhanced Tumorigenic and Metastatic Potential of Cancer Cells.

Authors:  Yoojung Kwon; Youngmi Kim; Sangkyung Eom; Misun Kim; Deokbum Park; Hyuna Kim; Kyeonga Noh; Hansoo Lee; Yun Sil Lee; Jongseon Choe; Young Myeong Kim; Dooil Jeoung
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

3.  Macrophage activation by heparanase is mediated by TLR-2 and TLR-4 and associates with plaque progression.

Authors:  Miry Blich; Amnon Golan; Gil Arvatz; Anat Sebbag; Itay Shafat; Edmond Sabo; Victoria Cohen-Kaplan; Sirouch Petcherski; Shani Avniel-Polak; Amnon Eitan; Haim Hammerman; Doron Aronson; Elena Axelman; Neta Ilan; Gabriel Nussbaum; Israel Vlodavsky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-15       Impact factor: 8.311

Review 4.  Matrix modeling and remodeling: A biological interplay regulating tissue homeostasis and diseases.

Authors:  Nikos K Karamanos; Achilleas D Theocharis; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2018-08-18       Impact factor: 11.583

5.  Heparanase: Cloning, Function and Regulation.

Authors:  Shaun M Gaskin; Tatiana P Soares Da Costa; Mark D Hulett
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

6.  Fibroblast heterogeneity and its impact on extracellular matrix and immune landscape remodeling in cancer.

Authors:  Mitsuo Yamauchi; Don L Gibbons; Chenghang Zong; Jared J Fradette; Neus Bota-Rabassedas; Jonathan M Kurie
Journal:  Matrix Biol       Date:  2020-05-19       Impact factor: 11.583

7.  Role of the autocrine chemokines MIP-1alpha and MIP-1beta in the metastatic behavior of murine T cell lymphoma.

Authors:  Patricia Menten; Alessandra Saccani; Chris Dillen; Anja Wuyts; Sofie Struyf; Paul Proost; Alberto Mantovani; Ji Ming Wang; Jo Van Damme
Journal:  J Leukoc Biol       Date:  2002-10       Impact factor: 4.962

8.  Heparanase enhances myeloma progression via CXCL10 downregulation.

Authors:  U Barash; Y Zohar; G Wildbaum; K Beider; A Nagler; N Karin; N Ilan; I Vlodavsky
Journal:  Leukemia       Date:  2014-04-04       Impact factor: 11.528

9.  Overexpression of heparanase enhances T lymphocyte activities and intensifies the inflammatory response in a model of murine rheumatoid arthritis.

Authors:  Andreas Digre; Kailash Singh; Magnus Åbrink; Rogier M Reijmers; Stellan Sandler; Israel Vlodavsky; Jin-Ping Li
Journal:  Sci Rep       Date:  2017-04-12       Impact factor: 4.379

Review 10.  The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Authors:  Edward Hammond; Ashwani Khurana; Viji Shridhar; Keith Dredge
Journal:  Front Oncol       Date:  2014-07-24       Impact factor: 6.244

View more
  5 in total

1.  Induction of heparanase 2 (Hpa2) expression by stress is mediated by ATF3.

Authors:  Ibrahim Knani; Preeti Singh; Miriam Gross-Cohen; Sharon Aviram; Neta Ilan; Ralph D Sanderson; Ami Aronheim; Israel Vlodavsky
Journal:  Matrix Biol       Date:  2021-11-20       Impact factor: 11.583

2.  Molecular Mechanism of Gleditsiae Spina for the Treatment of High-Grade Serous Ovarian Cancer Based on Network Pharmacology and Pharmacological Experiments.

Authors:  Boran Zhang; Wenchao Dan; Ganlin Zhang; Xiaomin Wang
Journal:  Biomed Res Int       Date:  2022-03-08       Impact factor: 3.411

Review 3.  Extracellular matrix guidance of autophagy: a mechanism regulating cancer growth.

Authors:  Carolyn G Chen; Renato V Iozzo
Journal:  Open Biol       Date:  2022-01-05       Impact factor: 6.411

4.  Non-enzymatic heparanase enhances gastric tumor proliferation via TFEB-dependent autophagy.

Authors:  Min Yang; Bo Tang; Sumin Wang; Li Tang; Dalin Wen; Israel Vlodavsky; Shi-Ming Yang
Journal:  Oncogenesis       Date:  2022-08-15       Impact factor: 6.524

5.  Helicobacter pylori-Induced Heparanase Promotes H. pylori Colonization and Gastritis.

Authors:  Li Tang; Bo Tang; Yuanyuan Lei; Min Yang; Sumin Wang; Shiping Hu; Zhuo Xie; Yaojiang Liu; Israel Vlodavsky; Shiming Yang
Journal:  Front Immunol       Date:  2021-06-17       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.